Press release – Enhanc3D Genomics

Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform

20 October 2022/in Press release/by Alex Scott-Simons

GenLink3DTM provides the first high-resolution mapping of DNA interactions in 3D space, enabling the vast array of non-coding genetic variations to be deciphered into actionable disease biomarkers and treatment targets Funds will be used to rapidly generate deep datasets of novel diagnostic signatures and candidate therapeutic targets across multiple immune-related diseases for internal and external […]

1 July 2022/in Press release/by 3dgenoxdt

We had a great day at OnHelix conference held at Babraham Institute focussed on translating research into diagnostics and therapeutics. #onhelix22 #3DGenomics

ENHANC3D was spun out of Professor Peter Fraser’s pioneering 3D genome organisation research laboratory

1 June 2022/in Press release/by 3dgenoxdt

We are developing a technology to unlock the full potential of the 3D organisation of the #humangenome to identify #disease-associated #genetic interactions including those that are causal for disease susceptibility and progression.

ENHANC3D GENOMICS Awarded QuickFire Challenge Grant

26 March 2022/in Press release/by 3dgenoxdt

We are proud to be awarded the Johnson & Johnson Innovation QuickFire Challenge Grant which recognises the potential of our functional genomics platform, GenLink3D™.